CELLIVITY is available to adults only. Supplement pages are general product information; peptide records are not a sales offer and are not for human use.
Age confirmation is a declaration, not identity verification. Restricted research access still requires separate professional eligibility checks.Privacy and legal notice ↗
This is a combined research presentation containing materials labelled BPC-157 and TB-500. A blend is not a new evidence-backed treatment: each component still needs exact identity and content testing, and the mixture introduces additional stability and interaction questions.
Research focus
Two-component research blend for separately measured pathway work.
Current evidence context
There is no reliable controlled human evidence establishing benefit for this combination. Findings reported for either individual research topic cannot predict the performance or safety of the blend.
Questions this record follows
Can both components be identified and quantified independently in one vial?
Does co-formulation alter degradation, aggregation or analytical recovery?
Do controlled models show effects that differ from the single materials?
04 — LAB RESULTS & DOCUMENTS
One product. One place. One evidence trail.
Exact CELLIVITY-batch review is pending. Reference files below describe their own declared samples.
Purity, identity, per-vial content and sterility are separate results.
Product
BPC-157 + TB-500
Record
CEL-P-BTB-001
Files received
0
0 FILES
No product-specific laboratory file has been uploaded yet.
AVAILABILITY
Tell us what your lab needs.
Request current availability for a lawful institutional, analytical or laboratory purpose. We confirm the exact presentation, price, batch and document state before any next step.
Exact presentation review
Jurisdiction and purpose check
Batch-document confirmation
No medical or human-use guidance
SELECTED PRODUCTBPC-157 + TB-500CEL-P-BTB-001 · response after manual review
BPC-157 + TB-500: before you enquire
What exactly does the selected format mean?＋
The mg or IU value is the declared material content per vial; it is not the container volume. Your selected presentation and quantity are saved with your enquiry. The final price is confirmed in the response.
Which batch will be supplied?＋
The specific batch and its documents are confirmed in the response. Files shown here may be supplier reference samples; the current record does not yet contain a qualified CELLIVITY lot dossier.
When can it arrive in Thailand?＋
For confirmed local stock, the planned window is 2–3 working days in Thailand. Pattaya timing is agreed directly. Incoming or specially sourced products have a separate estimate, confirmed before a commitment.
Can I enquire about several products together?＋
Yes. Add each format and quantity to the cart, then send one availability enquiry. Your selected items are kept together for review.
CELLIVITY
BPC-157 + TB-500
CEL-P-BTB-001 · 5 mg + 5 mg / 10 mg + 10 mg
This is a combined research presentation containing materials labelled BPC-157 and TB-500. A blend is not a new evidence-backed treatment: each component still needs exact identity and content testing, and the mixture introduces additional stability and interaction questions.
Two-component research blend for separately measured pathway work.
Follow the sources
There is no reliable controlled human evidence establishing benefit for this combination. Findings reported for either individual research topic cannot predict the performance or safety of the blend.
Can both components be identified and quantified independently in one vial?
Does co-formulation alter degradation, aggregation or analytical recovery?
Do controlled models show effects that differ from the single materials?
Lab documents
CELLIVITY lot review pending
No lab files received
A blend compounds identity, stability, sterility and safety uncertainty; evidence cannot be inferred from its individual labels.
